BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10609660)

  • 1. Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates.
    Brann T; Kayda D; Lyons RM; Shirley P; Roy S; Kaleko M; Smith T
    Hum Gene Ther; 1999 Dec; 10(18):2999-3011. PubMed ID: 10609660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vector.
    Andrews JL; Shirley PS; Iverson WO; Sherer AD; Markovits JE; King L; Lyons RM; Kaleko M; Connelly S
    Hum Gene Ther; 2002 Jul; 13(11):1331-6. PubMed ID: 12162815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
    Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
    Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.
    Reddy PS; Sakhuja K; Ganesh S; Yang L; Kayda D; Brann T; Pattison S; Golightly D; Idamakanti N; Pinkstaff A; Kaloss M; Barjot C; Chamberlain JS; Kaleko M; Connelly S
    Mol Ther; 2002 Jan; 5(1):63-73. PubMed ID: 11786047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac mice.
    Bristol JA; Shirley P; Idamakanti N; Kaleko M; Connelly S
    Mol Ther; 2000 Sep; 2(3):223-32. PubMed ID: 10985953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes.
    Andrews JL; Weaver L; Kaleko M; Connelly S
    Haemophilia; 1999 May; 5(3):160-8. PubMed ID: 10444282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A.
    Brown BD; Shi CX; Powell S; Hurlbut D; Graham FL; Lillicrap D
    Blood; 2004 Feb; 103(3):804-10. PubMed ID: 14512318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
    Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice.
    Connelly S; Smith TA; Dhir G; Gardner JM; Mehaffey MG; Zaret KS; McClelland A; Kaleko M
    Hum Gene Ther; 1995 Feb; 6(2):185-93. PubMed ID: 7537539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.
    Gallo-Penn AM; Shirley PS; Andrews JL; Kayda DB; Pinkstaff AM; Kaloss M; Tinlin S; Cameron C; Notley C; Hough C; Lillicrap D; Kaleko M; Connelly S
    Hum Gene Ther; 1999 Jul; 10(11):1791-802. PubMed ID: 10446919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice.
    Ishiwata A; Mimuro J; Mizukami H; Kashiwakura Y; Takano K; Ohmori T; Madoiwa S; Ozawa K; Sakata Y
    J Gene Med; 2009 Nov; 11(11):1020-9. PubMed ID: 19757487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level tissue-specific expression of functional human factor VIII in mice.
    Connelly S; Gardner JM; McClelland A; Kaleko M
    Hum Gene Ther; 1996 Jan; 7(2):183-95. PubMed ID: 8788169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice.
    Connelly S; Andrews JL; Gallo-Penn AM; Tagliavacca L; Kaufman RJ; Kaleko M
    Thromb Haemost; 1999 Feb; 81(2):234-9. PubMed ID: 10063998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs.
    Gallo-Penn AM; Shirley PS; Andrews JL; Tinlin S; Webster S; Cameron C; Hough C; Notley C; Lillicrap D; Kaleko M; Connelly S
    Blood; 2001 Jan; 97(1):107-13. PubMed ID: 11133749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A mice.
    Brown BD; Shi CX; Rawle FE; Tinlin S; McKinven A; Hough C; Graham FL; Lillicrap D
    J Thromb Haemost; 2004 Jan; 2(1):111-8. PubMed ID: 14717974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration.
    Nunes FA; Furth EE; Wilson JM; Raper SE
    Hum Gene Ther; 1999 Oct; 10(15):2515-26. PubMed ID: 10543616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.
    Smith TA; Idamakanti N; Marshall-Neff J; Rollence ML; Wright P; Kaloss M; King L; Mech C; Dinges L; Iverson WO; Sherer AD; Markovits JE; Lyons RM; Kaleko M; Stevenson SC
    Hum Gene Ther; 2003 Nov; 14(17):1595-604. PubMed ID: 14633402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial correction of murine hemophilia A with neo-antigenic murine factor VIII.
    Sarkar R; Gao GP; Chirmule N; Tazelaar J; Kazazian HH
    Hum Gene Ther; 2000 Apr; 11(6):881-94. PubMed ID: 10779165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of a novel epitope-tagged human factor VIII-encoding adenoviral vector.
    Roy S; Shirley PS; Connelly S; Andrews JL; Kayda DB; Gardner JM; Kaleko M
    Haemophilia; 1999 Sep; 5(5):340-8. PubMed ID: 10583516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.